Sweden · Delayed Price · Currency is SEK AlzeCure Pharma AB Statistics
Total Valuation
STO:ALZCUR has a market cap or net worth of SEK 159.16 million. The enterprise value is 128.48 million.
| Market Cap | 159.16M |
| Enterprise Value | 128.48M |
Important Dates
The next confirmed earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ALZCUR has 114.91 million shares outstanding. The number of shares has increased by 28.01% in one year.
| Current Share Class | 114.91M |
| Shares Outstanding | 114.91M |
| Shares Change (YoY) | +28.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.23% |
| Owned by Institutions (%) | 10.41% |
| Float | 69.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 14.18 |
| P/TBV Ratio | 14.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.17 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.36 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -231.88 |
Financial Efficiency
Return on equity (ROE) is -433.79% and return on invested capital (ROIC) is -251.71%.
| Return on Equity (ROE) | -433.79% |
| Return on Assets (ROA) | -113.69% |
| Return on Invested Capital (ROIC) | -251.71% |
| Return on Capital Employed (ROCE) | -440.85% |
| Weighted Average Cost of Capital (WACC) | 4.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.92M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -14,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.47% in the last 52 weeks. The beta is -0.04, so STO:ALZCUR's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -43.47% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 2.25 |
| Relative Strength Index (RSI) | 43.32 |
| Average Volume (20 Days) | 123,984 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -59.59M |
| Pretax Income | -59.23M |
| Net Income | -59.22M |
| EBITDA | -58.36M |
| EBIT | -59.59M |
| Earnings Per Share (EPS) | -0.55 |
Balance Sheet
The company has 32.97 million in cash and 2.29 million in debt, with a net cash position of 30.68 million or 0.27 per share.
| Cash & Cash Equivalents | 32.97M |
| Total Debt | 2.29M |
| Net Cash | 30.68M |
| Net Cash Per Share | 0.27 |
| Equity (Book Value) | 11.23M |
| Book Value Per Share | 0.10 |
| Working Capital | 9.72M |
Cash Flow
| Operating Cash Flow | -41.26M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | -1.09M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ALZCUR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.01% |
| Shareholder Yield | -28.01% |
| Earnings Yield | -37.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |